The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 7 July 2009, www.theannals.com, DOI 10.1345/aph.1M017.
The Annals of Pharmacotherapy: Vol. 43, No. 7, pp. 1227-1232. DOI 10.1345/aph.1M017
© 2009 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lockwood, A.
Right arrow Articles by Botts, S. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lockwood, A.
Right arrow Articles by Botts, S. R

PSYCHIATRY

Medication Adherence and Its Effect on Relapse Among Patients Discharged from a Veterans Affairs Posttraumatic Stress Disorder Treatment Program

Anna Lockwood, PharmD BCPP

Clinical Pharmacist, Psychiatry, Lexington VA Medical Center, Lexington, KY

Douglas T Steinke, PhD

Assistant Professor of Pharmacy Practice, Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington

Sheila R Botts, PharmD BCPP

Assistant Professor of Pharmacy Practice, Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky

Reprints: Dr. Lockwood, Lexington VA Medical Center, 1101 Veteran's Dr., CD-119, Lexington, KY 40502, fax 859/281-4851, anna.lockwood{at}va.gov

BACKGROUND: Clinical outcomes in patients with posttraumatic stress disorder (PTSD) can be affected by several factors, including medication adherence. PTSD is associated with an increased likelihood of missed appointments, medication underuse or abuse, and treatment nonadherence.

OBJECTIVE: To evaluate medication adherence and its effect on relapse following discharge of veterans from a PTSD residential rehabilitation program (PRRP).

METHODS: A retrospective evaluation of drug adherence and relapse in the 12 months following discharge of patients from a PRRP was performed. All veterans who were discharged from January 1, 2005, to December 31, 2006, and were receiving antidepressant therapy were included. Adherence to antidepressant therapy was assessed by electronic prescription claims and defined as a medication possession ratio of at least 0.8 in the year following discharge. Relapse was defined as a hospitalization for psychiatric symptomatology. Predictive factors of adherence were also explored.

RESULTS: Twenty-eight of the 82 (34%) veterans included in our study were adherent to medication during the 12 months following discharge. Seventeen (20.7%) veterans were rehospitalized for psychiatric symptoms, but nonadherence was not significantly associated with relapse (p = 0.91). The total number of drugs that a veteran received was related to adherence; patients who had a higher median number of medications were more adherent (p = 0.014). Age, comorbid substance abuse, combat service, and service connection were not associated with drug adherence.

CONCLUSIONS: The majority of patients who were discharged from a residential PTSD treatment program were nonadherent to antidepressant drug therapy. One in 5 veterans with PTSD was rehospitalized within 1 year; however, medication adherence did not affect this outcome.

Key Words: medication adherence, medication persistence, medication possession ratio, posttraumatic stress disorder

Published Online, July 7, 2009. www.theannals.com, DOI 10.1345/aph.1M017





homecopy help contact us subscription past issues search current issue
Copyright © 2009 by Harvey Whitney Books Company.